NCT04407481View on ClinicalTrials.gov

PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

October 13, 2022

Study Completion Date

October 13, 2022

Conditions
Polycystic Kidney Disease, AdultPolycystic Kidney, Autosomal Dominant
Interventions
DRUG

Aminohippurate Sodium Inj 20%

Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)

DRUG

Iohexol Inj 300 milligrams per milliliter (MG/ML)

Diagnostic aid/agent used to measure glomerular filtration rate (GFR)

RADIATION

PET/CT Scan

Imaging used to visualize the kidneys and quantify renal metabolic activity

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT04407481 - PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN) | Biotech Hunter | Biotech Hunter